Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab

Stephanie Rico*, Ifat Sher, Fabio Lavinksy, Daniel Lavinksy, Ygal Rotenstreich

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The purpose of this case report is to outline the management of a 41-year-old female with pathological myopia and type II choroidal neovascularization (CNV) diagnosed by optical coherence tomography angiography (OCT-A) angio-B mode. Observations: The early detection of CNV with OCT-A angio-B mode and treatment with intra-vitreous injections of Bevacizumab contributed to the amelioration of her vision to 20/20, a better visual acuity than she had prior to treatment. Conclusions and importance: This case report suggests that an OCT-A scan may reveal the initial formation of abnormal vasculature before pathological changes are evident in structural OCT, allowing for prompt treatment and resolution in patients with myopic CNV.

Original languageEnglish
Article number102041
JournalAmerican Journal of Ophthalmology Case Reports
Volume34
DOIs
StatePublished - Jun 2024

Keywords

  • Angio-B mode
  • Bevacizumab
  • Choroidal neovascularization
  • Myopia
  • Optical coherence tomography angiography

Fingerprint

Dive into the research topics of 'Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab'. Together they form a unique fingerprint.

Cite this